. 2012 Mar 8;22(3):253–291. doi: 10.1517/13543776.2012.667403
© Informa UK, Ltd.
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
Figure 2.
The distribution of patents on pyrazolines over the period 2000 – 2010.